Literature DB >> 19390802

Utility of family studies in diagnosing abnormal hemoglobins/thalassemic states.

Aruna Rangan1, A Handoo, S Sinha, R Saxena, I C Verma, S Kumar, S K Sood, M Bhargava.   

Abstract

OBJECTIVE: To resolve all indeterminate cases on HPLC screening with the help of family studies and to further confirm the results by genetic analysis.
METHODS: In our 11 years experience with HPLC at Sir Ganga Ram Hospital, we solved many cases with the help of family studies on parental blood samples in which patient could have possibly been homozygous vs compound heterozygous. Genetic analysis was done on index case as well as on parental samples with ARMS-PCR technique to confirm the results.
RESULTS: In 100% of cases, we noted that the diagnosis obtained by family studies was commensurate with that obtained by DNA analysis.
CONCLUSION: In centers, which do not have the facility for genetic analysis, family studies by HPLC can be equally useful.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19390802     DOI: 10.1007/s12098-009-0082-5

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  8 in total

1.  HPLC retention time as a diagnostic tool for hemoglobin variants and hemoglobinopathies: a study of 60000 samples in a clinical diagnostic laboratory.

Authors:  Alla Joutovsky; Joan Hadzi-Nesic; Michael A Nardi
Journal:  Clin Chem       Date:  2004-10       Impact factor: 8.327

2.  Rapid analysis of hemoglobin variants by cation-exchange HPLC.

Authors:  C N Ou; C L Rognerud
Journal:  Clin Chem       Date:  1993-05       Impact factor: 8.327

3.  Comparison of the relative quantities of gamma-mRNAs and fetal hemoglobin in SS patients with different haplotypes.

Authors:  N S Smetanina; L H Gu; T H Huisman
Journal:  Acta Haematol       Date:  1998       Impact factor: 2.195

4.  Automated HPLC screening of newborns for sickle cell anemia and other hemoglobinopathies.

Authors:  J W Eastman; R Wong; C L Liao; D R Morales
Journal:  Clin Chem       Date:  1996-05       Impact factor: 8.327

5.  Hemoglobinopathies : community clues to mutation detection.

Authors:  J M Old
Journal:  Methods Mol Med       Date:  1996

6.  Case report of HbC/beta(0)-thalassemia from India.

Authors:  S Kumar; M Rana; A Handoo; R Saxena; I C Verma; M Bhargava; S K Sood
Journal:  Int J Lab Hematol       Date:  2007-10       Impact factor: 2.877

7.  Screening cord blood for hemoglobinopathies and thalassemia by HPLC.

Authors:  F P van der Dijs; G A van den Berg; J G Schermer; F D Muskiet; H Landman; F A Muskiet
Journal:  Clin Chem       Date:  1992-09       Impact factor: 8.327

8.  Application of diagnostic methods and molecular diagnosis of hemoglobin disorders in Khuzestan province of Iran.

Authors:  Rahim Fakher; Kaeikhaei Bijan; Akbari Mohammad Taghi
Journal:  Indian J Hum Genet       Date:  2007-01
  8 in total
  3 in total

1.  HPLC in characterization of hemoglobin profile in thalassemia syndromes and hemoglobinopathies: a clinicohematological correlation.

Authors:  Rachna Khera; Tejinder Singh; Nita Khuana; Naresh Gupta; A P Dubey
Journal:  Indian J Hematol Blood Transfus       Date:  2014-06-05       Impact factor: 0.900

2.  Spectrum of haemoglobinopathies diagnosed by cation exchange-HPLC & modulating effects of nutritional deficiency anaemias from north India.

Authors:  Seema Rao; Rakhee Kar; Sanjeev Kumar Gupta; Anita Chopra; Renu Saxena
Journal:  Indian J Med Res       Date:  2010-11       Impact factor: 2.375

3.  Hemoglobin E Prevalence among Ethnic Groups Residing in Malaria-Endemic Areas of Northern Thailand and Its Lack of Association with Plasmodium falciparum Invasion In Vitro.

Authors:  Pathrapol Lithanatudom; Jiraprapa Wipasa; Pitsinee Inti; Kriangkrai Chawansuntati; Saovaros Svasti; Suthat Fucharoen; Daoroong Kangwanpong; Jatupol Kampuansai
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.